A global view of atherothrombosis:baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Bhatt, Deepak L, Fox, Keith A, Hacke, Werner, Berger, Peter B, Black, Henry R, Boden, William E, Cacoub, Patrice, Cohen, Eric A, Creager, Mark A, Easton, J Donald, Flather, Marcus D, Haffner, Steven M, Hamm, Christian W, Hankey, Graeme J, Johnston, S Claiborne, Mak, Koon-Hou, Mas, Jean-Louis, Montalescot, Gilles, Pearson, Thomas A, Steg, P Gabriel, Steinhubl, Steven R, Weber, Michael A, Booth, Joan, Topol, Eric J and , CHARISMA Investigators (2005) A global view of atherothrombosis:baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. American Heart Journal, 150 (3). 401.e1. ISSN 0002-8703

Full text not available from this repository. (Request a copy)

Abstract

The manifestations of atherothrombosis such as myocardial infarction, ischemic stroke, limb ischemia, or cardiovascular death pose a global health care burden. Additional therapies to decrease ischemic events in patients with established vascular disease or at risk for developing vascular disease are necessary. We sought to characterize the risk factors and treatments of a diverse contemporary population of patients with atherothrombosis.

Item Type: Article
Uncontrolled Keywords: adult,aged,aged, 80 and over,brain ischemia,cardiovascular diseases,coronary disease,female,humans,ischemia,leg,male,middle aged,myocardial infarction,risk factors,ticlopidine
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 06 Jan 2014 14:56
Last Modified: 21 Apr 2020 22:34
URI: https://ueaeprints.uea.ac.uk/id/eprint/46285
DOI: 10.1016/j.ahj.2005.03.017

Actions (login required)

View Item View Item